What is the role of pegfilgrastim in the DD-MVACarbo chemotherapy regimen?
Label:chem
Topic
The study includes the use of pegfilgrastim as a supportive measure in the chemotherapy regimen.
Answer
Pegfilgrastim is used to support the patient's neutrophil count during chemotherapy. It is administered subcutaneously at a dose of 3.6 mg on day 3 or 4 to help prevent neutropenia and reduce the risk of infections.
Return to Home
Chemical List
Knowledge you may be interested in